Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

February 4, 2013
Aims to identify commercialization opportunities   Read More »
January 31, 2013
Ends investment in cancer drug   Read More »
January 28, 2013
Launches EDA concept   Read More »
January 28, 2013
Non-exclusive deal for oral antiviral combos   Read More »
January 28, 2013
Will explore hydroponic system in biopharma protein system   Read More »
January 25, 2013
AZ takes on preclinical development of OX-CLI program   Read More »
January 25, 2013
Aims to address skills shortage faced by UK companies   Read More »
January 21, 2013
Biocatalysis expertise successfully transferred   Read More »
January 18, 2013
Add Nordic countries   Read More »
January 17, 2013
Will use Xtend technology for therapeutic antibody   Read More »
January 17, 2013
To develop delivery platform for cancer treatments   Read More »
January 17, 2013
Paladin granted rights to market APN311 in Canada and Africa   Read More »
January 16, 2013
To explore inhaled delivery for pulmonary fibrosis drug   Read More »
January 16, 2013
Delivers second preclinical drug candidate   Read More »
January 14, 2013
Will support BI’s drug discovery programs   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On